Serotonin 5-HT3 Receptor Antagonists

Name
Serotonin 5-HT3 Receptor Antagonists
Accession Number
DBCAT002341  (DBCAT001738, DBCAT003341, DBCAT003736)
Description

Drugs that bind to but do not activate SEROTONIN 5-HT3 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT3 RECEPTOR AGONISTS.

Drugs
DrugDrug Description
AlosetronA 5-HT3 antagonist used to treat diarrhea-predominant IBS.
DolasetronAn antinauseant and antiemetic used in chemotherapy and postoperatively.
EsmirtazapineInvestigated for use/treatment in insomnia and sleep disorders.
GranisetronA 5HT3 antagonist used to treat nausea and vomiting in cancer therapy and postoperatively.
MirtazapineA tetracyclic antidepressant used in the treatment of major depression and is used off-label as a drug for insomnia and to increase appetite.
OndansetronA serotonin 5-HT3 receptor antagonist used to prevent nausea and vomiting in cancer chemotherapy and postoperatively.
PalonosetronA serotonin antagonist used in the prophylaxis or management of vomiting that results from emetogenic chemotherapy, and for the management of postoperative nausea and vomiting.
TropisetronA 5HT-3 receptor antagonist used as an antiemetic in the treatment of chemotherapy-induced nausea and vomiting.
VortioxetineA serotonin modulating antidepressant indicated for the treatment of major depressive disorder (MDD).